Gene · 8648
Papers3,138
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,138
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Confirmation of high-throughput screening data and novel mechanistic insights into FXR-xenobiotic interactions by orthogonal assays. | Curr Res Toxicol | 2022 | 36353521 | PubTator, text mining | PubMed |
| SOX2 Modulates the Nuclear Organization and Transcriptional Activity of the Glucocorticoid Receptor. | J Mol Biol | 2022 | 36309135 | PubTator, text mining | PubMed |
| ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. | Nat Commun | 2022 | 36307405 | PubTator, text mining | PubMed |
| Identification of energy metabolism-related biomarkers for risk prediction of heart failure patients using random forest algorithm. | Front Cardiovasc Med | 2022 | 36304554 | PubTator, text mining | PubMed |
| Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma. | Ann Surg Treat Res | 2022 | 36304189 | PubTator, text mining | PubMed |
| Nuclear size rectification: A potential new therapeutic approach to reduce metastasis in cancer. | Front Cell Dev Biol | 2022 | 36299481 | PubTator, text mining | PubMed |
| Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity-When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood. | Int J Mol Sci | 2022 | 36293446 | PubTator, text mining | PubMed |
| Small Biopsy Samples: Are They Representative for Biphenotypic Sinonasal Sarcoma? | Diagnostics (Basel) | 2022 | 36292216 | PubTator, text mining | PubMed |
| Nuclear Proteomics of Induced Leukemia Cell Differentiation. | Cells | 2022 | 36291090 | PubTator, text mining | PubMed |
| Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer. | Curr Oncol | 2022 | 36290895 | PubTator, text mining | PubMed |
| miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation. | Sci Rep | 2022 | 36289359 | PubTator, text mining | PubMed |
| Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus. | Mayo Clin Proc Innov Qual Outcomes | 2022 | 36277502 | PubTator, text mining | PubMed |
| Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36263323 | PubTator, text mining | PubMed |
| Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers. | Front Oncol | 2022 | 36263200 | PubTator, text mining | PubMed |
| Aberrant expression of microRNA-4443 (miR-4443) in human diseases. | Bioengineered | 2022 | 36250718 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer. | Evid Based Complement Alternat Med | 2022 | 36248436 | PubTator, text mining | PubMed |
| Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family. | Front Endocrinol (Lausanne) | 2022 | 36246927 | PubTator, text mining | PubMed |
| Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia. | Int J Mol Sci | 2022 | 36233223 | PubTator, text mining | PubMed |
| Deep Learning Approaches for Detection of Breast Adenocarcinoma Causing Carcinogenic Mutations. | Int J Mol Sci | 2022 | 36232840 | PubTator, text mining | PubMed |
| Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. | Int J Mol Sci | 2022 | 36232796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8648/papers?page=15